BDBM350525 N-(4-bromophenyl)-2-(4,4-dimethyl- 2,5-dioxoimidazolidin-1-yl)acetamide::US10208071, Table 3.1::US10434112, Table 3.1::US10799518, Structure TABLE 3.1

SMILES CC1(C)NC(=O)N(CC(=O)Nc2ccc(Br)cc2)C1=O

InChI Key InChIKey=DEQTXYOBBWGLMS-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350525   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350525(N-(4-bromophenyl)-2-(4,4-dimethyl- 2,5-dioxoimidaz...)
Affinity DataEC50:  7.19E+5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350525(N-(4-bromophenyl)-2-(4,4-dimethyl- 2,5-dioxoimidaz...)
Affinity DataEC50:  719nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350525(N-(4-bromophenyl)-2-(4,4-dimethyl- 2,5-dioxoimidaz...)
Affinity DataEC50:  719nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent